Anticipating PTSD in severe COVID survivors: the case for screen-and-treat

Talya Greene, Sharif El-Leithy, Jo Billings, Idit Albert, Jennifer Birch, Mari Campbell, Kim Ehntholt, Lorna Fortune, Nicola Gilbert, Nick Grey, Laurinne Hana, Helen Kennerley, Deborah Lee, Sarah Lunn, Dominic Murphy, Mary Robertson, Dorothy Wade, Chris R. Brewin, Michael A.P. Bloomfield

Research output: Contribution to journalLetterpeer-review


Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

Original languageEnglish
Article number1959707
JournalEuropean Journal of Psychotraumatology
Issue number1
StatePublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.


  • PTSD assessment
  • Psychological trauma
  • critical care
  • intensive care
  • long COVID
  • mental health screening
  • COVID-19/epidemiology
  • Mass Screening
  • Pandemics
  • Humans
  • Survivors/psychology
  • Stress Disorders, Post-Traumatic/diagnosis

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Anticipating PTSD in severe COVID survivors: the case for screen-and-treat'. Together they form a unique fingerprint.

Cite this